Eduardo A. Scodeller
Mendoza, M, Argentina
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Protective Efficacy of a Mucosal Influenza Vaccine Formulation Based on the Recombinant Nucleoprotein Co-Administered with a TLR2/6 Agonist BPPcysMPEG.
Journal: Pharmaceutics
Published: December 09, 2022
Total Leishmania antigens with Poly(I:C) induce Th1 protective response.
Journal: Parasite immunology
Published: July 03, 2017
Intranasal delivery of influenza rNP adjuvanted with c-di-AMP induces strong humoral and cellular immune responses and provides protection against virus challenge.
Journal: PloS one
Published: April 11, 2014
Impact of tumor necrosis factor receptor p55 deficiency in susceptibility of C57BL/6 mice to infection with Leishmania (Leishmania) amazonensis.
Journal: Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi
Published: January 29, 2014
Immunization with antigenic extracts of Leishmania associated with Montanide ISA 763 adjuvant induces partial protection in BALB/c mice against Leishmania (Leishmania) amazonensis infection.
Journal: Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi
Published: September 30, 2013
Development of a universal CTL-based vaccine for influenza.
Journal: Bioengineered
Published: January 23, 2013
Enhancement of Th1 immune responses to recombinant influenza nucleoprotein by Ribi adjuvant.
Journal: The new microbiologica
Published: November 19, 2012
Improved immune response to recombinant influenza nucleoprotein formulated with ISCOMATRIX.
Journal: Journal of microbiology and biotechnology
Published: March 28, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026